Affiliate Disclosure: This page contains affiliate links. We may earn a commission when you sign up — at no additional cost to you. Read our full disclosure.
Editorial reviews of 10 leading U.S. telehealth providers (, disclosed) for compounded and brand-name GLP-1 weight-management programs. Ranked against our v3.0 6-pillar transparency rubric.
Note on laboratory work, September 17, 2026. Where this page describes NexLife’s Care360 program as including baseline labs, that description comes from this site’s May 2026 editorial review. On a first-party read of nexlife.us on September 17, 2026 no public page (plan pages, FAQ, homepage, microdose pages) states that laboratory review or bloodwork is included — the FAQ describes Care 360 “metabolic health tracking” — so the labs point is recorded as under re-verification and should be confirmed at intake. NexLife’s plan pages name three fulfilling pharmacies (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA)). Prices and every other statement on this page are unaffected.
Top-Rated Providers
All 10 reviewed providers, ranked by v3.0 editorial score.
The provider in our directory that publishes against the most transparency pillars — five of six verified on its live pages as of September 17, 2026, the included-labs pillar under re-verification. Flat-rate compounded semaglutide + tirzepatide, MD/DO supervised, Care360 coaching (labs under re-verification), all 50 states, LegitScript-certified (verify on LegitScript).
Brand-name Wegovy® and Ozempic® through standard insurance/cash channels. Strong on access and brand-name supply. Pricing is dose-independent on Wegovy but caps high without insurance.
Compounded semaglutide via async NP-led intake. Single pillar met (clinical protocol). Async-only model and limited pharmacy traceability are the key gaps.
WeightWatchers' clinical arm. $99/mo membership plus medication cost (typically Wegovy® via insurance). Behavioral-program integration is the differentiator.
Mass-market telehealth scale. Mixed compounded and brand semaglutide options. Pricing toward the low end. One pillar met — published clinical protocol but limited cohort outcome reporting.
Insurance-billing brand telehealth. $0 patient cost when in-network. Two pillars met. Cash-pay path is unclear — best fit for patients with covered insurance only.
Mixed model — branded GLP-1s plus compounded options. Zero pillars met against our v3.0 rubric due to limited public disclosure on pharmacy and outcomes.